Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Eton Pharmaceuticals, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Eton Pharmaceuticals appointed Judith Matthews as Executive Vice President of Accounting and Finance, with her assuming the CFO role on June 1, 2026, succeeding James Gruber. This leadership transition signals organizational continuity in financial management during a critical period for the company.
Key Takeaways
Judith Matthews appointed as EVP of Accounting and Finance effective immediately, becoming CFO on June 1, 2026
James Gruber remains as CFO through May 31, 2026, then transitions to a six-month consulting role to ensure smooth handoff
2 more takeaways
Related Filings (2)
2 more filings from Eton Pharmaceuticals, Inc. in the last 90 days